103 related articles for article (PubMed ID: 9440061)
1. Helicobacter pylori eradication in duodenal ulcer disease is cost-beneficial: a Belgian model.
Deltenre M; Ilunga KO
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():107-13. PubMed ID: 9440061
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Jönsson B
Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
O'Brien B; Goeree R; Mohamed AH; Hunt R
Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of H. pylori eradication.
Roesch W
J Physiol Pharmacol; 1996 Mar; 47(1):71-7. PubMed ID: 8777309
[No Abstract] [Full Text] [Related]
6. The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden.
Unge P; Jönsson B; Stålhammar NO
Pharmacoeconomics; 1995 Nov; 8(5):410-27. PubMed ID: 10160075
[TBL] [Abstract][Full Text] [Related]
7. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
Carrère MO; Auquier P; Poynard T; Sambuc R
Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
[TBL] [Abstract][Full Text] [Related]
8. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
Cutler AF; Vakil N
Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
[TBL] [Abstract][Full Text] [Related]
9. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
10. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
Schütze K; Hentschel E; Hirschl AM
Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
Massarrat S; Ihm P; Koch HK
Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428
[TBL] [Abstract][Full Text] [Related]
13. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
Khor CJ; Fock KM; Ng TM; Teo EK; Sim CS; Tan AL; Ng A
Singapore Med J; 2000 Aug; 41(8):382-6. PubMed ID: 11256345
[TBL] [Abstract][Full Text] [Related]
15. [Choice of anti-helicobacter treatment of gastroduodenal ulcer associated with helicobater pylori].
Starostin BD
Ter Arkh; 1999; 71(8):46-50. PubMed ID: 10515037
[TBL] [Abstract][Full Text] [Related]
16. [Cost-effectiveness analysis of the eradication of Helicobacter pylori as treatment for duodenal ulcer].
Fernández Muñoz J; López de Andrés A; Zapater Hernández P; Abad Santos F
An Med Interna; 1998 Oct; 15(10):515-22. PubMed ID: 9844225
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
19. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
[TBL] [Abstract][Full Text] [Related]
20. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
